• LIVING WITH CRC

    Pharmacist-Led Skin Toxicity Management for Anti-EGFR Therapy

    A retrospective study of 95 patients receiving anti-EGFR antibodies for advanced or recurrent colorectal cancer evaluated pharmacist-led pre-consultation interviews for skin toxicity assessment, finding that pharmacist recommendations contributed to dermatological toxicity management and multidisciplinary care. (Int J Clin Pharmacol Ther)